Hui Wang

机构：Central South University, Shanghai Jiao Tong University, Peking University, Ruijin Hospital, Tongren Hospital, Hunan Cancer Hospital, Second Affiliated Hospital of Nanjing Medical University, Peking University Third Hospital, Beijing Haidian Hospital, Guangzhou Medical University · ORCID：0000-0002-1440-8942

发表论文 62 篇 · 总被引 1160 次 · h-index 18

代表论文

• The Use of NACSELD and EASL-CLIF Classification Systems of ACLF in the Prediction of Prognosis in Hospitalized Patients With Cirrhosis (2020 · The American Journal of Gastroenterology · 被引 58)
• αPD-1-mesoCAR-T cells partially inhibit the growth of advanced/refractory ovarian cancer in a patient along with daily apatinib (2021 · Journal for ImmunoTherapy of Cancer · 被引 47)
• Diffusion-Weighted Magnetic Resonance Imaging-Guided Dose Painting in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent Chemoradiotherapy: A Randomized, Controlled Clinical Trial (2022 · International Journal of Radiation Oncology*Biology*Physics · 被引 39)
• Gut microbial metabolite 4-hydroxybenzeneacetic acid drives colorectal cancer progression via accumulation of immunosuppressive PMN-MDSCs (2025 · Journal of Clinical Investigation · 被引 38)
• Laboratory-based Surveillance and Clinical Profile of Sporadic HEV Infection in Shanghai, China (2021 · Virologica Sinica · 被引 23)
• Effect of overall lifestyle on the all-cause mortality and cardiovascular disease death in dyslipidemia patients with or without lipid-lowering therapy: a cohort study (2023 · BMC Cardiovascular Disorders · 被引 14)